Variation in Shrimp Allergens: Place of Origin Effects on Food Safety Assessment

Int J Mol Sci. 2024 Apr 20;25(8):4531. doi: 10.3390/ijms25084531.

Abstract

Due to the widespread use of shellfish ingredients in food products, accurate food labelling is urgently needed for consumers with shellfish allergies. Most crustacean allergen detection systems target the immunorecognition of the allergenic protein tropomyosin. However, this mode of detection may be affected by an origin-dependent protein composition. This study determined if the geographic location of capture, or aquaculture, influenced the allergenic protein profiles of Black Tiger Shrimp (Penaeus monodon), one of the most farmed and consumed shrimp species worldwide. Protein composition was analysed in shrimp from nine different locations in the Asia-Pacific by SDS-PAGE, immunoblotting, and mass spectrometry. Ten of the twelve known shrimp allergens were detected, but with considerable differences between locations. Sarcoplasmic calcium-binding protein, myosin light chain, and tropomyosin were the most abundant allergens in all locations. Hemocyanin-specific antibodies could identify up to six different isoforms, depending on the location of origin. Similarly, tropomyosin abundance varied by up to 13 times between locations. These findings suggest that allergen abundance may be related to shrimp origin and, thus, shrimp origin might directly impact the readout of commercial crustacean allergen detection kits, most of which target tropomyosin, and this should be considered in food safety assessments.

Keywords: allergen ELISA; crustacean allergens; food allergen proteomics; mass spectrometric analysis of allergens; shellfish; tropomyosin.

MeSH terms

  • Allergens* / analysis
  • Allergens* / immunology
  • Animals
  • Food Safety*
  • Penaeidae* / immunology
  • Shellfish / adverse effects
  • Shellfish / analysis
  • Shellfish Hypersensitivity / immunology
  • Tropomyosin* / immunology

Substances

  • Allergens
  • Tropomyosin

Grants and funding

This research was funded by the National Health and the Medical Research Council Australia (NHMRC; project grant GNT1086656 to A.L.L.). S.D.K. is an NHMRC Peter Doherty Early Career Research Fellow (GNT1124143).